K993375

Substantially Equivalent

CDS LTX CONTROL LATEX PARTICLE SUSPENSION AND PRIMER

Applicant: Clinical Diagnostic Solutions, Inc.
Product code: KRX
Advisory panel: Hematology
Date received: 1999-10-07
Decision date: 1999-12-20
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Plantation, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.